Similar articles

• [Secondary leukemia following chemotherapy of various malignancies].

  Abe T, Tsuda S, Takino T. Abe T, et al. Gan No Rinsho. 1984 Sep;30(12 Suppl):1543-52. Gan No Rinsho. 1984. PMID: 6513006 Japanese.
• Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies.

  Abe T, Tsuda S, Maekawa T, Taniwaki M, Sonoda Y, Ide T, Misawa S, Takino T, Inoue K. Abe T, et al. Cancer Treat Rep. 1985 May;69(5):505-14. Cancer Treat Rep. 1985. PMID: 4005873
• Incidence, previous treatment and chromosome characteristics of secondary acute non-lymphocytic leukemia.

  Pedersen-Bjergaard J. Pedersen-Bjergaard J. Cancer Treat Rev. 1985 Mar;12(1):65-75. doi: 10.1016/0305-7372(85)90013-1. Cancer Treat Rev. 1985. PMID: 3896485 Review. No abstract available.
• Leukemogenic risk prediction of the cytostatic treatment.

  Raposa T, Varkonyi J. Raposa T, et al. Prog Clin Biol Res. 1990;340D:53-63. Prog Clin Biol Res. 1990. PMID: 2196584 Review. No abstract available.
• [Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo].

  Shcheglova EG, Chebotarev AN. Shcheglova EG, et al. Biull Eksp Biol Med. 1983 Dec;96(12):67-9. Biull Eksp Biol Med. 1983. PMID: 6419793 Russian.